These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25241013)

  • 1. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
    Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification.
    Kara K; Gronewold J; Neumann T; Mahabadi AA; Weimar C; Lehmann N; Berger K; Kälsch HI; Bauer M; Broecker-Preuss M; Möhlenkamp S; Moebus S; Jöckel KH; Erbel R; Hermann DM
    Eur J Neurol; 2014 Jun; 21(6):914-21. PubMed ID: 24661834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.
    Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA
    J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
    Inohara T; Kim S; Pieper K; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Ezekowitz MD; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Mahaffey KW; Singer DE; Freeman JV; Steinberg BA; Peterson ED; Piccini JP;
    Heart; 2019 Mar; 105(5):370-377. PubMed ID: 30228248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative high N-terminal pro-B-type natriuretic peptide level can predict the incidence of postoperative atrial fibrillation following off-pump coronary artery bypass grafting.
    Matsuura K; Mogi K; Sakurai M; Kawamura T; Misue T; Hatakeyama I; Takahara Y
    Ann Thorac Cardiovasc Surg; 2013; 19(5):375-81. PubMed ID: 23269269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incident atrial fibrillation in systemic sclerosis: the predictive role of B-type natriuretic peptide.
    Giallafos I; Triposkiadis F; Oikonomou E; Giamouzis G; Aggeli K; Konstantopoulou P; Kouranos V; Mavrikakis M; Giallafos J; Stefanadis C; Sfikakis PP
    Hellenic J Cardiol; 2014; 55(4):313-21. PubMed ID: 25039027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Doukky R; Gage H; Nagarajan V; Demopoulos A; Cena M; Garcia-Sayan E; Karam GJ; Kazlauskaite R
    Echocardiography; 2013 Sep; 30(8):889-95. PubMed ID: 23496263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations.
    Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF
    Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
    Chua W; Law JP; Cardoso VR; Purmah Y; Neculau G; Jawad-Ul-Qamar M; Russell K; Turner A; Tull SP; Nehaj F; Brady P; Kastner P; Ziegler A; Gkoutos GV; Pavlovic D; Ferro CJ; Kirchhof P; Fabritz L
    PLoS Med; 2021 Feb; 18(2):e1003405. PubMed ID: 33534825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study.
    Pant R; Patel M; Garcia-Sayan E; Wassouf M; D'Silva O; Kehoe RF; Doukky R
    Cardiovasc Ultrasound; 2016 Jan; 14():4. PubMed ID: 26772738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation.
    Sakamoto Y; Sato S; Kuronuma Y; Nagatsuka K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2014; 23(5):799-804. PubMed ID: 24103668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
    Schnabel RB; Larson MG; Yamamoto JF; Sullivan LM; Pencina MJ; Meigs JB; Tofler GH; Selhub J; Jacques PF; Wolf PA; Magnani JW; Ellinor PT; Wang TJ; Levy D; Vasan RS; Benjamin EJ
    Circulation; 2010 Jan; 121(2):200-7. PubMed ID: 20048208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
    Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
    Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.